PERITONEAL CANCER
Clinical trials for PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shrinks tumors in Platinum-Sensitive ovarian cancer
Disease control CompletedThis study tested a drug called mirvetuximab soravtansine in 79 adults with recurrent ovarian, peritoneal, or fallopian tube cancer that still responds to platinum chemotherapy and has high levels of a protein called folate receptor-alpha. The main goal was to see how many partic…
Matched conditions: PERITONEAL CANCER
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Chatbot aims to boost genetic testing in cancer survivors
Knowledge-focused CompletedThis study tested a digital tool (a chatbot) to help cancer survivors learn about genetic testing for hereditary cancer risk. 50 adults who had certain cancers (like breast, ovarian, or prostate) took part. The goal was to see if the chatbot was easy to use and if it helped more …
Matched conditions: PERITONEAL CANCER
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated May 17, 2026 04:35 UTC
-
PET scans may help tailor chemo for stomach and ovarian cancer patients
Knowledge-focused CompletedThis study tested whether repeated FDG-PET/CT scans can help doctors choose patients and measure treatment response in people with cancer spread in the abdomen (peritoneal metastasis) who receive a special chemotherapy called PIPAC. 34 patients with cancers like stomach, colorect…
Matched conditions: PERITONEAL CANCER
Sponsor: Odense University Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 04:29 UTC
-
Real-World ovarian cancer drug study completed: what happened to 388 patients?
Knowledge-focused CompletedThis study looked at 388 women with advanced ovarian, fallopian tube, or peritoneal cancer who were taking the drug niraparib as ongoing maintenance treatment. Researchers tracked side effects and treatment patterns in routine UK clinics, without giving any new treatment. The goa…
Matched conditions: PERITONEAL CANCER
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 17, 2026 04:18 UTC
-
Ovarian cancer genetics study aims to unlock clues for better treatment
Knowledge-focused CompletedThis study looked at 1,500 women with advanced ovarian, peritoneal, or fallopian tube cancer to see how genetic changes in their tumors relate to how long they live without the disease getting worse. Researchers collected tumor samples and medical information to build a database …
Matched conditions: PERITONEAL CANCER
Sponsor: ARCAGY/ GINECO GROUP • Aim: Knowledge-focused
Last updated May 17, 2026 04:15 UTC